BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8347480)

  • 1. Structural and functional contributions to the G1 blocking action of the retinoblastoma protein. (the 1992 Gordon Hamilton Fairley Memorial Lecture).
    Livingston DM; Kaelin W; Chittenden T; Qin X
    Br J Cancer; 1993 Aug; 68(2):264-8. PubMed ID: 8347480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RB and hbrm cooperate to repress the activation functions of E2F1.
    Trouche D; Le Chalony C; Muchardt C; Yaniv M; Kouzarides T
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11268-73. PubMed ID: 9326598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastoma (Rb) protein upregulates expression of the Ifi202 gene encoding an interferon-inducible negative regulator of cell growth.
    Xin H; Pramanik R; Choubey D
    Oncogene; 2003 Jul; 22(31):4775-85. PubMed ID: 12894219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
    Srethapakdi M; Liu F; Tavorath R; Rosen N
    Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
    Fan G; Ma X; Kren BT; Steer CJ
    Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells.
    Christoffersen J; Smeland EB; Stokke T; Taskén K; Andersson KB; Blomhoff HK
    Cancer Res; 1994 Apr; 54(8):2245-50. PubMed ID: 8174134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reintroduction of a normal retinoblastoma gene into retinoblastoma and osteosarcoma cells inhibits the replication associated function of SV40 large T antigen.
    Uzvolgyi E; Classon M; Henriksson M; Huang HJ; Szekely L; Lee WH; Klein G; Sumegi J
    Cell Growth Differ; 1991 Jun; 2(6):297-303. PubMed ID: 2064998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein.
    Xu HJ; Xu K; Zhou Y; Li J; Benedict WF; Hu SX
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9837-41. PubMed ID: 7937901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.
    Zhang HS; Gavin M; Dahiya A; Postigo AA; Ma D; Luo RX; Harbour JW; Dean DC
    Cell; 2000 Mar; 101(1):79-89. PubMed ID: 10778858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dibutyryl cyclic AMP enhances the down-regulation of RB protein during G1 phase in the proliferating primary rat hepatocytes, but inhibits their entries into S phase and RB's phosphorylation.
    Okamoto Y; Kikuchi E; Matsumoto M; Nakano H
    Biochem Biophys Res Commun; 1993 Aug; 195(1):84-9. PubMed ID: 8395839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication.
    Chen QM; Bartholomew JC; Campisi J; Acosta M; Reagan JD; Ames BN
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):43-50. PubMed ID: 9576849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle.
    Goodrich DW; Wang NP; Qian YW; Lee EY; Lee WH
    Cell; 1991 Oct; 67(2):293-302. PubMed ID: 1655277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p300 is required for orderly G1/S transition in human cancer cells.
    Iyer NG; Xian J; Chin SF; Bannister AJ; Daigo Y; Aparicio S; Kouzarides T; Caldas C
    Oncogene; 2007 Jan; 26(1):21-9. PubMed ID: 16878158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death.
    Knudsen KE; Weber E; Arden KC; Cavenee WK; Feramisco JR; Knudsen ES
    Oncogene; 1999 Sep; 18(37):5239-45. PubMed ID: 10498874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FMS (CSF-1 receptor) prolongs cell cycle and promotes retinoic acid-induced hypophosphorylation of retinoblastoma protein, G1 arrest, and cell differentiation.
    Yen A; Sturgill R; Varvayanis S; Chern R
    Exp Cell Res; 1996 Nov; 229(1):111-25. PubMed ID: 8940255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of cancer suppression by the retinoblastoma gene.
    Lee WH
    Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophosphorylation of the RB protein in S and G2 as well as G1 during growth arrest.
    Yen A; Sturgill R
    Exp Cell Res; 1998 Jun; 241(2):324-31. PubMed ID: 9637774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division.
    Zatulovskiy E; Zhang S; Berenson DF; Topacio BR; Skotheim JM
    Science; 2020 Jul; 369(6502):466-471. PubMed ID: 32703881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered mutants of pRB with improved growth suppression potential.
    Antelman D; Perry S; Hollingsworth R; Gregory RJ; Driscoll B; Fung YK; Bookstein R
    Oncogene; 1997 Dec; 15(23):2855-66. PubMed ID: 9419977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells.
    Münster PN; Srethapakdi M; Moasser MM; Rosen N
    Cancer Res; 2001 Apr; 61(7):2945-52. PubMed ID: 11306472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.